Literature DB >> 17048278

Intra-anal collagen injection for the treatment of faecal incontinence.

S G Stojkovic1, M Lim, D Burke, P J Finan, P M Sagar.   

Abstract

BACKGROUND: Intra-anal injectable agents have been used to treat faecal incontinence. The aim of this study was to report the experience of a cohort of patients who underwent intra-anal injection of collagen and to determine which patients benefited from the technique.
METHODS: Data, including age, sex, incontinence score, classification of incontinence, baseline resting pressure and vector volume, were collected prospectively for 73 consecutive patients (59 women) undergoing intra-anal collagen injection. Patients were reviewed after treatment and incontinence scores documented. A proportion of patients also underwent repeat anorectal physiological testing 8 weeks after the procedure.
RESULTS: At a median follow-up of 12 months after the intra-anal injection, 63 per cent of patients had an improved incontinence score and 73 per cent reported an overall improvement in symptoms. Logistic regression showed that older age and idiopathic faecal incontinence were predictors of a successful outcome (P = 0.042 and P = 0.048 respectively).
CONCLUSION: Intra-anal collagen injection appears to have a role in the treatment of faecal incontinence. The majority of patients can expect both objective and subjective improvement. The best results are achieved in older patients and in those with idiopathic incontinence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17048278     DOI: 10.1002/bjs.5394

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

Review 1.  Current status: new technologies for the treatment of patients with fecal incontinence.

Authors:  Andreas M Kaiser; Guy R Orangio; Massarat Zutshi; Suraj Alva; Tracy L Hull; Peter W Marcello; David A Margolin; Janice F Rafferty; W Donald Buie; Steven D Wexner
Journal:  Surg Endosc       Date:  2014-03-08       Impact factor: 4.584

2.  An Evidence-Based Approach to the Evaluation, Diagnostic Assessment and Treatment of Fecal Incontinence in Women.

Authors:  Isuzu Meyer; Holly E Richter
Journal:  Curr Obstet Gynecol Rep       Date:  2014-09

3.  Injectable synthetic calcium hydroxylapatite ceramic microspheres (Coaptite) for passive fecal incontinence.

Authors:  E Ganio; F Marino; I Giani; A Realis Luc; G Clerico; E Novelli; M Trompetto
Journal:  Tech Coloproctol       Date:  2008-06-10       Impact factor: 3.781

4.  The use of Permacol® injections for the treatment of faecal incontinence.

Authors:  Zeiad I Hussain; Michael Lim; Haider Mussa; Kazim Abbas; Stevan Stojkovic
Journal:  Updates Surg       Date:  2012-09-05

5.  Treatment of fecal incontinence - review of observational studies (OS) and randomized controlled trials (RCT) related to injection of bulking agent into peri-anal tissue.

Authors:  Felix W Leung
Journal:  J Interv Gastroenterol       Date:  2011-10-01

6.  An Open-Label, Noncomparative, Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx Gel as a Bulking Agent for the Treatment of Fecal Incontinence.

Authors:  Giuseppe Dodi; Johannes Jongen; Fernando de la Portilla; Manoj Raval; Donato F Altomare; Paul-Antoine Lehur
Journal:  Gastroenterol Res Pract       Date:  2010-12-27       Impact factor: 2.260

7.  Novel bulking agent for faecal incontinence.

Authors:  C Ratto; A Parello; L Donisi; F Litta; V De Simone; L Spazzafumo; P Giordano
Journal:  Br J Surg       Date:  2011-09-16       Impact factor: 6.939

8.  Multicentre observational study of the Gatekeeper for faecal incontinence.

Authors:  C Ratto; S Buntzen; F Aigner; D F Altomare; A Heydari; L Donisi; L Lundby; A Parello
Journal:  Br J Surg       Date:  2015-12-01       Impact factor: 6.939

9.  Identifying factors associated with clinical success in patients treated with NASHA(®)/Dx injection for fecal incontinence.

Authors:  Howard Franklin; Andrew C Barrett; Ray Wolf
Journal:  Clin Exp Gastroenterol       Date:  2016-03-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.